GlassScriptPhysician profile
Hilary James Evans
NPI 1619916301
$8,361.91
in general payments reported to CMS, 2019-2025
56 companies · $1,785 in 2025
The $1,785 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $281 · 2021: $1,170 · 2022: $1,082 · 2023: $1,270 · 2024: $1,554 · 2025: $1,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,609.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.76 | 2019-2025 | |
| Pfizer INC. | $793.49 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $614.81 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $592.97 | 2019-2025 | Evenity, Prolia, Otezla |
| Novo Nordisk INC | $546.59 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $515.18 | 2019-2025 | |
| Glaxosmithkline, LLC. | $471.55 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $309.53 | 2019-2023 | Trintellix |
| Lilly USA, LLC | $247.11 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $244.65 | 2021-2025 | |
| Astellas Pharma US INC | $224.77 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $216.19 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $212.42 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $183.52 | 2023-2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $175.94 | 2021-2025 | Injectafer |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilary Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.